January PCE inflation rose 0.3% for annual rate of 2.5%, meeting Dow Jones expectations
Personal consumption expenditures inflation rose 0.3% in January for an annual rate of 2.5%, the Bureau of Economic Analysis ...
Inflation Steady in January, Meeting Expectations as Consumers Backed Away From Large Purchases
While the consumer price index is more well known, the PCE is used by the Fed in its forecasts. For now, the central bank is ...
Tokyo’s Slowing Consumer Inflation Cools BOJ Rate Increase Expectations
Consumer inflation in the Tokyo metropolitan area grew at a slower pace in February, cooling speculation about an early ...
PCE inflation gauge matches expectations, offering relief to Fed
The latest reading of the Federal Reserve's preferred inflation gauge showed prices rose on a monthly basis but dropped year ...
Jump in inflation expectations bad news for Trump, the Fed, and all Americans
The survey director noted that long-range inflation expectations have increased quickly, calling it an “unusually large ...
Hosted on MSN6h
Americans Now Expect 4.3% Inflation—A Big Jump In Just 3 Months
Americans’ inflation expectations have surged to 4.3%, marking one of the sharpest three-month increases since 1979, ...
cnbctv1810h
US Inflation Rate Highlights: S&P 500 is flat after in-line inflation data
The US Bureau of Economic Analysis will release the January PCE Price Index at 7:00 PM today, a key inflation gauge that ...
US consumer spending declines; annual inflation subsides
U.S. consumer spending unexpectedly fell in January while the annual increase in inflation slowed, supporting financial ...
Inflation is easing, but another alarm bell is ringing about the US economy
The Federal Reserve’s preferred inflation gauge cooled as expected in January; however, the good news came with another ...
The PCE report, the Fed's preferred inflation measure, is out. Here's what it says.
A large majority of Americans say their incomes aren't keeping pace with inflation. Here's what the numbers say.
Nautilus: Trading Below An Albeit Lower Net Cash Figure
Nautilus Biotechnology, Inc. eyes commercialization by 2026, facing reflexivity risks and macroeconomic challenges. Click for ...